HAYNES BARTON F has a total of 42 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 1993. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Israel. Its main competitors in its focus markets biotechnology, pharmaceuticals and environmental technology are CODIAK BIOSCIENCES INC, HER MAJESTY THE QUEEN IN RIGHT OF CANADA AS REPRESENTED BY THE MINI OF HEALTH and CT NAC DE SANIDAD AGROPECUARIA.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 26 | |
#2 | WIPO (World Intellectual Property Organization) | 12 | |
#3 | Israel | 4 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Environmental technology | |
#4 | Measurement | |
#5 | Micro-structure and nano-technology | |
#6 | Agriculture |
# | Name | Total Patents |
---|---|---|
#1 | Haynes Barton F | 38 |
#2 | Liao Hua-Xin | 21 |
#3 | Alam S Munir | 8 |
#4 | Moody M Anthony | 6 |
#5 | Leslie S Johnson | 4 |
#6 | Guido Ferrari | 4 |
#7 | Sempowski Gregory D | 4 |
#8 | Scott Koenig | 4 |
#9 | Barton F Haynes | 4 |
#10 | Chia-Ying Kao Lam | 4 |
Publication | Filing date | Title |
---|---|---|
US2012269821A1 | Hiv-1 antibodies | |
WO2012011955A2 | Compositions and methods for production and screening of monoclonal antibodies | |
US2011305700A1 | Anti-lipid antibodies | |
US2012070488A1 | Method of inducing neutralizing antibodies to human immunodeficiency virus | |
WO2008082439A2 | Antigen specific nanoparticles | |
US2008057075A1 | Method of inducing neutralizing antibodies to human immunodeficiency virus | |
US2009136522A1 | Multivalent Immunogen | |
US2008038284A1 | Human Immunodeficiency Virus Vaccine | |
US2008085261A1 | Vaccine Adjuvant | |
WO2005016238A2 | Severe acute respiratory syndrome | |
WO9315750A1 | Use of synthetic peptides to induce tolerance to pathogenic t and b cell epitopes of autoantigens |